Flu Study with Peramivir In Hospitalised Patients

• Research type

  Research Study

• Full title

  A Phase 3, Multicenter, Randomized, Double-Blind, Controlled Study to Evaluate the Efficacy and Safety of Peramivir Administered Intravenously in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents who are Hospitalized due to Serious Influenza.

• IRAS ID

  35465

• Sponsor organisation

  BioCryst Pharmaceuticals, Inc.

• Eudract number

  2009-012367-34

• Clinicaltrials.gov Identifier

  NCT00958776

• Research summary

  N/A

• REC name

  East Midlands - Leicester South Research Ethics Committee

• REC reference

  09/H0402/100

• Date of REC Opinion

  12 Nov 2009

• REC opinion

  Further Information Favourable Opinion